Loading company…
N-of-One offers clinical variant interpretation services that help molecular oncology labs handle growing test volumes.
Founded in 2007 and based in Concord, US, N-of-One was acquired by Qiagen in January 2019, with terms not disclosed. Its QCI Precision Insights service gives oncologist-vetted, evidence-based interpretations of molecular data for hematologic malignancies. The company's Series B round raised USD 7.00 mn from investors including Allumia Ventures and Excel Venture Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in